Sanofi (NEO:SAN)

Market Cap	157.71B -22.0%
Revenue (ttm)	75.21B +5.5%
Net Income	12.58B +40.5%
EPS	10.26 +43.6%
Shares Out	n/a
PE Ratio	12.54
Forward PE	9.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	600
Average Volume	11,727
Open	10.50
Previous Close	10.57
Day's Range	10.50 - 10.50
52-Week Range	9.78 - 11.60
Beta	0.36
RSI	54.12
Earnings Date	Apr 23, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for onc...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 74,846
• Stock Exchange: Cboe Canada
• Ticker Symbol: SAN

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.

Financial numbers in EUR